Gotham Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,896
| Closed | -$174K | – | 1142 |
|
|
2021
Q4 | $174K | Buy |
10,896
+1
| +0% | +$16 | 0.01% | 1089 |
|
|
2021
Q3 | $175K | Sell |
10,895
-726
| -6% | -$11.7K | 0.01% | 982 |
|
|
2021
Q2 | $161K | Buy |
11,621
+1,370
| +13% | +$19K | 0.01% | 959 |
|
|
2021
Q1 | $150K | Buy |
+10,251
| New | +$150K | 0.01% | 965 |
|
|
2020
Q4 | – | Sell |
-19,614
| Closed | -$360K | – | 1006 |
|
|
2020
Q3 | $360K | Sell |
19,614
-48,006
| -71% | -$881K | 0.01% | 804 |
|
|
2020
Q2 | $1.21M | Sell |
67,620
-68,875
| -50% | -$1.23M | 0.04% | 516 |
|
|
2020
Q1 | $2.21M | Buy |
136,495
+14,012
| +11% | +$227K | 0.06% | 388 |
|
|
2019
Q4 | $2.21M | Buy |
122,483
+104,968
| +599% | +$1.89M | 0.04% | 449 |
|
|
2019
Q3 | $355K | Buy |
+17,515
| New | +$355K | 0.01% | 870 |
|
|
2017
Q2 | – | Sell |
-36,380
| Closed | -$769K | – | 977 |
|
|
2017
Q1 | $769K | Buy |
36,380
+3,398
| +10% | +$71.8K | 0.01% | 708 |
|
|
2016
Q4 | $928K | Buy |
32,982
+15,619
| +90% | +$439K | 0.01% | 630 |
|
|
2016
Q3 | $465K | Buy |
+17,363
| New | +$465K | 0.01% | 720 |
|